ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,901Medicare Part D Prescriptions Filled, Including Refills

Rank: 200 out of 1206

$472K Total Retail Price of All Prescriptions

Rank: 194 out of 1206

341 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 341 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

20% of this provider’s 341 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 7,925 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $46 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
OMEPRAZOLE 412 372 1 3
FUROSEMIDE 368 315 2 5
LEVOTHYROXINE SODIUM 345 287 3 2
HYDROCODONE-ACETAMINOPHEN 345 272 S3 3 7
SIMVASTATIN 337 250 5 1
AMLODIPINE BESYLATE 294 264 6 6
LISINOPRIL 243 232 7 4
ATENOLOL 217 182 8 14
ATORVASTATIN CALCIUM 207 184 9 13
METFORMIN HCL 197 124 10 10
METOPROLOL SUCCINATE 169 125 11 15
CITALOPRAM HBR 167 162 12 16
POTASSIUM CHLORIDE 159 140 13 12
AZITHROMYCIN 150 108 14 46
GABAPENTIN 147 119 15 18
HYDROCHLOROTHIAZIDE 145 143 16 11
ENALAPRIL MALEATE 134 108 17 45
SERTRALINE HCL 131 107 18 22
METOPROLOL TARTRATE 128 105 19 9
RANITIDINE HCL 122 78 20 23
GLIPIZIDE 120 86 21 64
WARFARIN SODIUM 110 102 22 8
PROAIR HFA 108 93 23 49
ZOLPIDEM TARTRATE 104 102 24 25
CLOPIDOGREL 104 86 24 48
NEXIUM 102 90 26 47
ATENOLOL-CHLORTHALIDONE 96 85 27 170
ALLOPURINOL 94 86 28 24
LANTUS 86 59 29 38
PREDNISONE 79 76 30 28
PLAVIX 78 62 31 72
MIRTAZAPINE 77 49 32 50
CLONIDINE HCL 72 60 33 88
LEVOFLOXACIN 72 61 33 78
GLYBURIDE 71 38 R 35 69
OXYCODONE-ACETAMINOPHEN 70 69 S2 36 106
CRESTOR 64 50 37 30
TRAZODONE HCL 62 40 38 37
TAMSULOSIN HCL 59 48 39 26
FLUTICASONE PROPIONATE 58 45 40 42
NAPROXEN 58 46 40 105
METHADONE HCL 57 34 S2 42 167
ALENDRONATE SODIUM 57 48 42 19
DONEPEZIL HCL 56 49 44 29
PANTOPRAZOLE SODIUM 56 28 44 54
CIPROFLOXACIN HCL 54 46 46 61
FAMOTIDINE 53 41 47 65
ZETIA 52 51 48 73
INSULIN SYRINGE 51 24 49 111
CEPHALEXIN 50 40 50 62
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.